Breast cancer often begins quietly with the rapid and unchecked multiplication of cells within the breast's milk ducts or lobules. Regular self-exams, screenings, and early detection improves outcomes.
Starts in the milk ducts (most common type)
Can spread to surrounding tissues
Begins in the milk-producing lobules
May be harder to detect on imaging
Non-invasive, early-stage cancer confined to ducts
Nearly 100% treatable when caught early
Not true cancer but a risk marker
Indicates higher likelihood of
developing invasive cancer
Hormone receptor-positive (estrogen/progesterone)
HER2-negative Most common subtype
Lacks all three receptors (ER, PR, HER2)
More aggressive but responds to immunotherapy
Hormone receptor-positive
HER2-positive (protein overexpression)
Hormone receptor-negative
HER2-positive
Rare, aggressive form causing skin redness/swelling
Affects nipple skin (often with underlying DCIS/IDC)
Higher in women
Higher risk at after 55
BRCA1/2 mutations, family history
Radiation (<30), HRT, DES
Early periods (<12), late menopause (>55), late/no pregnancy
Obesity (post-menopause), alcohol, smoking, inactivity, poor diet
Dense breasts, past benign breast conditions
Oral contraceptives (slight risk increase)
Step 1: Initial Check-Up
(If you notice symptoms like a lump or changes)
What happens: Your doctor will:
Your role: Share any changes you’ve noticed openly.
Step 2: Imaging Tests Mammogram: Quick breast X-ray Ultrasound: Sound wave imaging MRI: Detailed scan (high-risk cases) PET/CT: Checks for spread (advanced cases)
Step 3: Biopsy (Definitive Test) (The only way to confirm cancer)
Types
Your role: Your comfort matters. Discuss pain relief options, take breaks
Step 4: Pathology and Lab Results (Takes a few days to a week)
What’s checked:
Your role: Bring a loved one to discuss results
Step 5: Staging Tests (To plan the best treatment)
TNM Staging System
Additional Tests Depending on the Cancer Type
Step 1: Initial Check-Up
(If you notice symptoms like a lump or changes)
What happens: Your doctor will:
Your role: Share any changes you’ve noticed openly.
Step 2
Imaging Tests
Step 3
Biopsy (Definitive Test)
Step 4
Pathology and Lab Results
Step 5
Staging Tests
Description:
Tumor + margin removed; breast conserved
Used For:
Early-stage (I-II), small tumors
Recovery:
1-2 weeks; +radiation
Description:
Full breast removal
Used For:
Large/multifocal tumors
Recovery:
4-6 weeks; reconstruction options
Description:
Sentinel biopsy or axillary dissection
Used For:
Check spread to lymph nodes
Recovery:
1-2 weeks
Method :
Daily sessions (5 days/week, 3-6 weeks)
Duration:
15-30 treatments
Side Effects :
Fatigue, skin redness, breast swelling
Method:
Radioactive seeds implanted near tumor
Duration:
1-5 days
Side Effects :
Short-term tenderness, skin changes
Target:
Fast-growing cells
Treatment Includes :
Neoadjuvant/Adjuvant
Side Effects :
Hair loss, nausea
Target:
ER/PR+ cancers
Treatment Includes:
Tamoxifen, Letrozole
Side Effects:
Hot flashes, fatigue, joint and muscle pain
Target:
HER2+ cancers
Treatment Includes:
Trastuzumab, Pertuzumab
Side Effects :
Nausea, headaches, breath shortness, bowel irregularities
Target:
TNBC (PD-L1+)
Treatment Includes:
Pembrolizumab, Atezolizumab
Side Effects :
Fever, weakness
Purpose :
Prevent fractures, bone loss
Procedures:
Bisphosphonates and Denosumab
Purpose:
Manage symptoms
Procedures:
Manage symptoms, side effects, stress through treatment and emotional, spiritual support
Survival :
99%
Treatment Approach :
Surgery ± radiation
Type:
DCIS, LCIS
Survival :
90%+
Treatment Approach :
Surgery + chemo/radiation
Type :
Early-Stage Cancer
Survival:
60-80%
Treatment Approach :
Aggressive combo therapy
Type:
Locally Advanced Cancer
Sruvival:
~29%
Treatment Approach:
Lifelong systemic therapy
Type:
Metastatic Cancer
For Whom?:
All women
Actions:
Healthy weight, exercise, limit alcohol
For Whom? :
BRCA+ or family history
Actions:
Annual MRI + mammogram, genetic counseling
For Whom?:
High-risk postmenopausal ER/PR+ cancers (post-treatment) HER2+ cancers (post treatment)
Actions:
Aromatase inhibitors Hormone therapy (to reduce recurrence risk) Targeted therapy (to reduce recurrence risk)
For Whom?:
BRCA+ carriers
Actions:
Prophylactic mastectomy
Fatigue, pain, or menopausal symptoms can linger. Talk to your doctor — options like physical therapy or meds can help.
Gentle activity (like yoga or walking) boosts energy. Eat nourishing, balanced meals to support recovery.
Regular scans and tests keep you on track and catch any changes early.
Very common. Support groups, mindfulness, or therapy can ease anxiety.
Scars, surgery, and hair loss may impact confidence. Explore reconstruction, prosthetics, or tattoos — or embrace your new body as it is.
Feeling lost afterward is normal. Reach out for mental health support if needed.
Be open with loved ones. Let them know how to support you.
Return at your pace. Ask about flexible work or financial aid if needed.
Some survivors find meaning in advocacy or helping others — but there’s no pressure.
Starts in the milk ducts (most common type)
Can spread to surrounding tissues
Begins in the milk-producing lobules
May be harder to detect on imaging
Non-invasive, early-stage cancer confined to ducts
Nearly 100% treatable when caught early
Not true cancer but a risk marker
Indicates higher likelihood of
developing invasive cancer
Hormone receptor-positive (estrogen/progesterone)
HER2-negative Most common subtype
Lacks all three receptors (ER, PR, HER2)
More aggressive but responds to immunotherapy
Hormone receptor-positive
HER2-positive (protein overexpression)
Hormone receptor-negative
HER2-positive
Rare, aggressive form causing skin redness/swelling
Affects nipple skin (often with underlying DCIS/IDC)
Higher in women
Higher risk at after 55
BRCA1/2 mutations, family history
Radiation (<30), HRT, DES
Early periods (<12), late menopause (>55), late/no pregnancy
Obesity (post-menopause), alcohol, smoking, inactivity, poor diet
Dense breasts, past benign breast conditions
Oral contraceptives (slight risk increase)
Step 1: Initial Check-Up
(If you notice symptoms like a lump or changes)
What happens: Your doctor will:
Your role: Share any changes you’ve noticed openly.
Step 2: Imaging Tests Mammogram: Quick breast X-ray Ultrasound: Sound wave imaging MRI: Detailed scan (high-risk cases) PET/CT: Checks for spread (advanced cases)
Step 3: Biopsy (Definitive Test) (The only way to confirm cancer)
Types
Your role: Your comfort matters. Discuss pain relief options, take breaks
Step 4: Pathology and Lab Results (Takes a few days to a week)
What’s checked:
Your role: Bring a loved one to discuss results
Step 5: Staging Tests (To plan the best treatment)
TNM Staging System
Additional Tests Depending on the Cancer Type
Step 1: Initial Check-Up
(If you notice symptoms like a lump or changes)
What happens: Your doctor will:
Your role: Share any changes you’ve noticed openly.
Step 2
Imaging Tests
Step 3
Biopsy (Definitive Test)
Step 4
Pathology and Lab Results
Step 5
Staging Tests
Description:
Tumor + margin removed; breast conserved
Used For:
Early-stage (I-II), small tumors
Recovery:
1-2 weeks; +radiation
Description:
Full breast removal
Used For:
Large/multifocal tumors
Recovery:
4-6 weeks; reconstruction options
Description:
Sentinel biopsy or axillary dissection
Used For:
Check spread to lymph nodes
Recovery:
1-2 weeks
Method :
Daily sessions (5 days/week, 3-6 weeks)
Duration:
15-30 treatments
Side Effects :
Fatigue, skin redness, breast swelling
Method:
Radioactive seeds implanted near tumor
Duration:
1-5 days
Side Effects :
Short-term tenderness, skin changes
Target:
Fast-growing cells
Treatment Includes :
Neoadjuvant/Adjuvant
Side Effects :
Hair loss, nausea
Target:
ER/PR+ cancers
Treatment Includes:
Tamoxifen, Letrozole
Side Effects:
Hot flashes, fatigue, joint and muscle pain
Target:
HER2+ cancers
Treatment Includes:
Trastuzumab, Pertuzumab
Side Effects :
Nausea, headaches, breath shortness, bowel irregularities
Target:
TNBC (PD-L1+)
Treatment Includes:
Pembrolizumab, Atezolizumab
Side Effects :
Fever, weakness
Purpose :
Prevent fractures, bone loss
Procedures:
Bisphosphonates and Denosumab
Purpose:
Manage symptoms
Procedures:
Manage symptoms, side effects, stress through treatment and emotional, spiritual support
Survival :
99%
Treatment Approach :
Surgery ± radiation
Type:
DCIS, LCIS
Survival :
90%+
Treatment Approach :
Surgery + chemo/radiation
Type :
Early-Stage Cancer
Survival:
60-80%
Treatment Approach :
Aggressive combo therapy
Type:
Locally Advanced Cancer
Sruvival:
~29%
Treatment Approach:
Lifelong systemic therapy
Type:
Metastatic Cancer
For Whom?:
All women
Actions:
Healthy weight, exercise, limit alcohol
For Whom? :
BRCA+ or family history
Actions:
Annual MRI + mammogram, genetic counseling
For Whom?:
High-risk postmenopausal ER/PR+ cancers (post-treatment) HER2+ cancers (post treatment)
Actions:
Aromatase inhibitors Hormone therapy (to reduce recurrence risk) Targeted therapy (to reduce recurrence risk)
For Whom?:
BRCA+ carriers
Actions:
Prophylactic mastectomy
Fatigue, pain, or menopausal symptoms can linger. Talk to your doctor — options like physical therapy or meds can help.
Gentle activity (like yoga or walking) boosts energy. Eat nourishing, balanced meals to support recovery.
Regular scans and tests keep you on track and catch any changes early.
Very common. Support groups, mindfulness, or therapy can ease anxiety.
Scars, surgery, and hair loss may impact confidence. Explore reconstruction, prosthetics, or tattoos — or embrace your new body as it is.
Feeling lost afterward is normal. Reach out for mental health support if needed.
Be open with loved ones. Let them know how to support you.
Return at your pace. Ask about flexible work or financial aid if needed.
Some survivors find meaning in advocacy or helping others — but there’s no pressure.
of all female cancer cases globally and in India
new cases diagnosed worldwide in 2022
of cases occur in men
No question is too small when it comes to your care
Yes, although rare, men can develop breast cancer. Early detection is equally important for men.
No. It increases your risk, but many people with no family history can also develop breast cancer.
Not necessarily. Many lumps are benign (non-cancerous), but any lump should be evaluated by a doctor.
Women over 40 should discuss mammogram screenings with their doctors annually or as recommended based on individual risk factors.
breast-cancer
Breast cancer symptoms
Breast cancer risk factors
Breast cancer prevention
Breast cancer types
Ductal carcinoma
Lobular carcinoma
Invasive breast cancer types
Invasive ductal carcinoma
Invasive lobular carcinoma
Inflammatory breast cancer
Triple-negative breast cancer
Invasive ductal carcinoma
Invasive lobular carcinoma
Inflammatory breast cancer
Triple-negative breast cancer
Breast cancer treatment
Triple-negative breast cancer treatment
Ductal carcinoma treatment
Inflammatory breast cancer treatment
Invasive ductal carcinoma treatment
Lobular carcinoma treatment
Invasive lobular carcinoma treatment
Breast cancer therapy
Radiation therapy for breast cancer
Chemotherapy for breast cancer
Hormone therapy for breast cancer
Neoadjuvant therapy breast cancer
Targeted therapy for breast cancer
Treatment of breast cancer by stages
Treatment of stage 1 breast cancer
Treatment of stage 2 breast cancer
Treatment of stage 3 breast cancer
Treatment of stage 4 breast cancer
Breast cancer diagnosis
Mammography test for breast cancer
Ultrasound test for breast cancer
Breast MRI scan
Breast biopsy test
Her2 testing in breast cancer
Genetic testing for breast cancer
Breast cancer screening
Breast cancer screening mammogram
Clinical breast exam
Breast cancer treatment in Gurgaon
Gurgaon EBD 65
EBD 65, Sector 65, Golf Course Extension Road, Gurgaon